NCT00054041View on ClinicalTrials.gov

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2007

Conditions
Cervical CancerCervical Intraepithelial Neoplasia Grade 3Human Papilloma Virus Infection
Interventions
BIOLOGICAL

HspE7

Given subcutaneously

PROCEDURE

therapeutic conventional surgery

Undergo large loop excision

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00054041 - Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter